Market Overview

Morgan Stanley Sees High Quality Growth Story For Monsanto

Share:
Related MON
Top 4 NYSE Stocks In The Agricultural Chemicals Industry With The Highest ROI
Monsanto Slightly Maintaining Gains Following Better-Than-Expected Earnings

In a report published Thursday, Morgan Stanley analyst Vincent Andrews reiterated an Overweight rating and $150.00 price target on Monsanto Company (NYSE: MON).

In the report, Morgan Stanley noted, “Reiterate $150 year-end PT as key tenant of $200 Bull Case is now in play: a $11B (~18% DSO) buyback should not only compound the high visibility growth from Intacta Soybeans (key Base Case driver) but it should also minimize commodity price concerns (a perennial overhang on the stock).”

Monsanto closed on Wednesday at $126.73.

Latest Ratings for MON

DateFirmActionFromTo
Jan 2015CitigroupMaintainsBuy
Jan 2015Deutsche BankMaintainsBuy
Jan 2015JP MorganMaintainsOverweight

View More Analyst Ratings for MON
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Vincent AndrewsAnalyst Color Reiteration Analyst Ratings

 

Related Articles (MON)

Around the Web, We're Loving...

Get Benzinga's Newsletters